Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Scanlon

Showing results (241-250 of 272) with videos related to

Pageof 28
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2003
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammationKaren Francis, B Mary Lewis, Hiroyasu Akatsu, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary levelF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|March 1, 1985
Relationships between the circadian rhythms of TSH, prolactin and cortisol in surgically treated microprolactinoma patientsJ Salvador, D W Wilson, P E Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1987
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitaryF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressinJ C Smith, H A Lane, J Lewis, et al.
Clinical Endocrinology|April 1, 1986
The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgeryM F Scanlon, J R Peters, J Salvador, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Anticonvulsant therapy and cortisol eliminationP J Evans, R F Walker, J R Peters, et al.
British Medical Journal (Clinical Research Ed.)|November 30, 1985
Management of selected patients with hyperprolactinaemia by partial hypophysectomyM F Scanlon, J R Peters, J P Thomas, et al.
Controlled Clinical Trials|December 1, 1989
Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentaryR T Chlebowski, G L Blackburn, D W Nixon, et al.
Pageof 28

Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2003
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammationKaren Francis, B Mary Lewis, Hiroyasu Akatsu, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1986
Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary levelF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|March 1, 1985
Relationships between the circadian rhythms of TSH, prolactin and cortisol in surgically treated microprolactinoma patientsJ Salvador, D W Wilson, P E Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1987
Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitaryF F Casanueva, L Villanueva, C Dieguez, et al.
Clinical Endocrinology|April 1, 1979
Comparison of long-acting analogues of luteinizing hormone releasing hormone in manJ A Wass, G M Besser, A Gomez-Pan, et al.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressinJ C Smith, H A Lane, J Lewis, et al.
Clinical Endocrinology|April 1, 1986
The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgeryM F Scanlon, J R Peters, J Salvador, et al.
British Journal of Clinical Pharmacology|August 1, 1985
Anticonvulsant therapy and cortisol eliminationP J Evans, R F Walker, J R Peters, et al.
British Medical Journal (Clinical Research Ed.)|November 30, 1985
Management of selected patients with hyperprolactinaemia by partial hypophysectomyM F Scanlon, J R Peters, J P Thomas, et al.
Controlled Clinical Trials|December 1, 1989
Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentaryR T Chlebowski, G L Blackburn, D W Nixon, et al.
Pageof 28